Two cases of pulmonary paragonimiasis on FDG-PET CT imaging

Annals of Nuclear Medicine

Volumn 20, Issue 4, 2006, Pages 311-315

  Yoo, Ie Ryung ^a   Park, Hyun Jin ^a   Hyun O, Joo ^a   Chung, Yong An ^a   Sohn, Hyung Sun ^a   Chung, Soo Kyo ^a   Kim, Sung Hoon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Lung; Paragonimiasis; Paragonimus westermani; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PRAZIQUANTEL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG INFECTION; MALE; PARAGONIMIASIS; PARAGONIMUS WESTERMANI; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; THORAX RADIOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARAGONIMIASIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745870447     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02984648     Document Type: Article

References (22)

1. Could MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. JAMA 2001; 285: 914-924.
2. 18F]-2-fluoro-deoxy-D-glucose positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 2004; 125: 1413-1423.
3. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004; 45: 19-27.
4. Imdahl A, Jenkner S, Brink I, Nitzsche E, Stoelben E, Moser E, et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg 2001; 20: 324-329.
5. Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216: 117-121.
6. Croft DR, Trapp J, Kernstine K, Kirchner P, Mullan B, Galvin J, et al. FDG-PET imaging and the diagnosis of nonsmall cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 2002; 36: 297-301.
7. Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S, et al. Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. Anticancer Res 2003; 23: 3437-3440.
8. Zhuang H, Duarte PS, Rebenstock A, Feng Q, Alavi A. Pulmonary clostridium perfringens infection detected by FDG positron emission tomography. Clin Nucl Med 2003; 28: 517-518.
9. Hsu CH, Lee CM, Wang FC, Lin YH. F-18 fluorodeoxyglucose positron emission tomography in pulmonary cryptococcoma. Clin Nucl Med 2003; 28: 791-793.
10. Wilkinson MD, Fulham MJ, McCaughan BC, Constable CJ. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography. Clin Nucl Med 2003; 28: 234-235.
11. Beggs AD, Hain SF. F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis. Clin Nucl Med 2002; 27: 705-706.
12. Talwar A, Mayerhoff R, London D, Shah R, Stanek A, Epstein M. False-positive PET scan in a patient with lipoid pneumonia simulating lung cancer. Clin Nucl Med 2004; 29: 426-428.
13. Kao CH, Tsai SC, Hung GU. Two incorrect FDG positron emission tomography interpretations of a pulmonary mass and mediastinal lymphadenopathy. Clin Nucl Med 2001; 26: 1049-1050.
14. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487-490.
15. Hubner KF, Buonocore E, Gould HR, Thie J, Smith GT, Stephens S, et al. Differentiating benign from malignant lung lesions using " quantitative" parameters of FDG PET images. Clin Nucl Med 1996; 21: 941-949.
16. Yang SN, Liang JA, Lin FJ, Kwan AS, Kao CH, Shen YY. Differentiating benign and malignant pulmonary lesions with FDG-PET. Anticancer Res 2001; 21: 4153-4157.
17. Schillaci O, Simonetti G. Fusion imaging in nuclear medicine-application of dual-modality systems in oncology. Cancer Biother Radiopharm 2004; 19: 1-10.
18. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412-1417.
19. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 2001; 28: 696-703.
20. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43: 871-875.
21. Mukae H, Taniguchi H, Matsumoto N, Iiboshi H, Ashitani J, Matsukura S, et al. Clinicoradiologic features of pleuropulmonary Paragonimus westermani on Kyusyu Island, Japan. Chest 2001; 120: 514-520.
22. DeFrain M, Hooker R. North American paragonimiasis, case report of a severe clinical infection. Chest 2002; 121: 1368-1372.